ABBV insider files Rule 144 to sell 62,755 shares; August sales disclosed

Rhea-AI Filing Summary

AbbVie Inc. (ABBV) Form 144 notice: An insider proposes to sell 62,755 shares of common stock through Morgan Stanley Smith Barney LLC on 08/22/2025. The shares were acquired the same day via a stock option exercise and paid for in cash. The filing lists an aggregate market value for the proposed sale of $13,231,264.20 and reports 1,766,558,253 shares outstanding for the class. The filer also reported four prior common-stock sales in August 2025 by Richard A. Gonzalez: 61,500 shares on 08/01/2025 35,120 shares and 91,600 shares on 08/04/2025 90,000 shares on 08/21/2025

Positive

• Transaction fully documented: Broker, acquisition method (stock option exercise), payment (cash), and proposed sale date are provided
• Insider attestation present: Signature block includes representation of no undisclosed material adverse information

Negative

• Insider sales volume: Multiple sizable sales in August 2025 totaling 288,220 shares by the same person may be viewed negatively by some investors
• Concentration of sales: Prior gross proceeds reported exceed $56 million across four transactions, indicating substantial insider liquidity

Insights

Securities Analyst

TL;DR: Insider exercised options and filed to sell 62,755 AbbVie shares; several sizable August sales were reported.

The filing documents a routine Rule 144 notice for sale of common shares following a stock option exercise and immediate cash payment. The proposed transaction is routed through Morgan Stanley Smith Barney LLC and the reported aggregate market value of the intended sale is $13.23 million. Recent August activity shows multiple block sales by the same individual, totaling 288,220 shares across four transactions, producing reported gross proceeds exceeding $56 million. For investors, this is a disclosure of insider liquidity rather than operational or financial performance information; it does not, by itself, indicate company-level changes.

Compliance/Risk Analyst

TL;DR: Filing appears to comply with Rule 144 disclosure requirements and includes standard insider attestation.

The notice includes required details: broker, number of shares, acquisition method, payment type, and prior three-month sales. The signer affirms there is no undisclosed material adverse information and notes potential criminal penalties for false statements. No conflicting information or procedural irregularities are evident in the provided text. Any compliance risk would depend on timeliness and accuracy relative to underlying records, which are not provided here.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza, 8th Floor New York NY 10004	62755	13231264.2	1766558253	08/22/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/22/2025	Stock Option Exercise	Issuer			62755	08/22/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Richard A. Gonzalez 1 North Waukegan Road North Chicago IL 60064	Common	08/01/2025	61500	12043268.25
Richard A. Gonzalez 1 North Waukegan Road North Chicago IL 60064	Common	08/04/2025	35120	6828296.22
Richard A. Gonzalez 1 North Waukegan Road North Chicago IL 60064	Common	08/04/2025	91600	19208000
Richard A. Gonzalez 1 North Waukegan Road North Chicago IL 60064	Common	08/21/2025	90000	18993947.76

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AbbVie (ABBV) Form 144 filed on 08/22/2025 report?

The filing reports a proposed sale of 62,755 common shares through Morgan Stanley Smith Barney LLC on 08/22/2025, acquired the same day via a stock option exercise and paid for in cash; aggregate market value listed is $13,231,264.20.

Who is the seller identified in the Form 144 for ABBV?

The filing lists prior August sales by Richard A. Gonzalez at an address in North Chicago, IL; the Form 144 sale is routed through Morgan Stanley Smith Barney LLC.

What prior sales by the insider are reported in the past three months?

Four sales in August 2025 are reported: 61,500 shares on 08/01/2025 35,120 and 91,600 shares on 08/04/2025 90,000 shares on 08/21/2025 (proceeds $18,993,947.76).

How many shares outstanding does the Form 144 list for AbbVie's class?

The filing reports 1,766,558,253 shares outstanding for the class of common stock.

Does the Form 144 include any indication of undisclosed material information?

The filer certifies by signing that they do not know of any material adverse information about the issuer that has not been publicly disclosed.